B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Reticulin

300 PubMed studies analyzed · 5 RCTs · Evidence Score: 46

Research Domains

Reticulin has been studied across 14 research domains including 🔬 Oncology, ✨ Skin & Hair, 🦴 Bone & Joint, 🫁 Liver & Detox, 🫘 Kidney. The primary research focus is 🔬 Oncology with 26% of studies addressing this area.

Loading evidence profile...

This evidence profile for Reticulin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.